Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Gadebusch

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
The American Review of Respiratory Disease|May 1, 1970
Long-lasting antituberculous activity of derivatives of 2-styrylquinolineF Pansy, W P Jambor, H H Gadebusch, et al.
The Journal of Antibiotics|March 1, 1987
Quaternary heterocyclylamino beta-lactams. VI. In vitro and in vivo antibacterial properties of L-642,946 and L-652,813, a long acting cephemB A Pelak, E C Gilfillan, B Weissberger, et al.
Chemotherapy|January 1, 1985
In vitro antibacterial activity of norfloxacin and other agents against ocular pathogensD L Shungu, V K Tutlane, E Weinberg, et al.
Infection|January 1, 1982
Comparison of the antibacterial activity of norfloxacin (MK 0366, AM 715), a new organic acid, with that of other orally absorbed chemotherapeutic agentsH H Gadebusch, D L Shungu, E Weinberg, et al.
The Journal of Antibiotics|January 1, 1983
Quaternary heterocyclylamino beta-lactams. IV. Comparison of the in vivo antibacterial activities of L-640,876, mecillinam, cefoxitin and cefotaximeE Celozzi, B A Pelak, E O Stapley, et al.
The Journal of Antibiotics|January 1, 1983
Quaternary heterocyclylamino beta-lactams. III. The mode of action of L-640,876 and the effect of NaCl on membrane permeability and bindingL R Koupal, B A Pelak, P J Cassidy, et al.
The Journal of Antibiotics|May 1, 1989
L-658,310, a new injectable cephalosporin. II. In vitro and in vivo interactions between L-658,310 and various aminoglycosides or ciprofloxacin versus clinical isolates of Pseudomonas aeruginosaM E Valiant, E C Gilfillan, H H Gadebusch, et al.
The Journal of Antibiotics|June 1, 1978
Diastereomeric 7-ureidoacetyl cephalosporins. III. Contribution of D- and L-isomers to the growth inhibiting activities of 7alpha-H and 7alpha-OCH3 derivatives for gram-positive and gram-negative bacteriaH H Gadebusch, H I Basch, P Lukaszow, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1974
Cephradine: absorption, excretion, and tissue distribution in animals of a new cephalosporin antibioticI Weliky, H H Gadebusch, K Kripalani, et al.
The Journal of Antibiotics|July 1, 1972
Comparative chemotherapeutic activities of heptaene macrolide antifungal antibiotics in experimental candidiasisF E Pansy, W P Jambor, J Wilber-Murphy, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
The American Review of Respiratory Disease|May 1, 1970
Long-lasting antituberculous activity of derivatives of 2-styrylquinolineF Pansy, W P Jambor, H H Gadebusch, et al.
The Journal of Antibiotics|March 1, 1987
Quaternary heterocyclylamino beta-lactams. VI. In vitro and in vivo antibacterial properties of L-642,946 and L-652,813, a long acting cephemB A Pelak, E C Gilfillan, B Weissberger, et al.
Chemotherapy|January 1, 1985
In vitro antibacterial activity of norfloxacin and other agents against ocular pathogensD L Shungu, V K Tutlane, E Weinberg, et al.
Infection|January 1, 1982
Comparison of the antibacterial activity of norfloxacin (MK 0366, AM 715), a new organic acid, with that of other orally absorbed chemotherapeutic agentsH H Gadebusch, D L Shungu, E Weinberg, et al.
The Journal of Antibiotics|January 1, 1983
Quaternary heterocyclylamino beta-lactams. IV. Comparison of the in vivo antibacterial activities of L-640,876, mecillinam, cefoxitin and cefotaximeE Celozzi, B A Pelak, E O Stapley, et al.
The Journal of Antibiotics|January 1, 1983
Quaternary heterocyclylamino beta-lactams. III. The mode of action of L-640,876 and the effect of NaCl on membrane permeability and bindingL R Koupal, B A Pelak, P J Cassidy, et al.
The Journal of Antibiotics|May 1, 1989
L-658,310, a new injectable cephalosporin. II. In vitro and in vivo interactions between L-658,310 and various aminoglycosides or ciprofloxacin versus clinical isolates of Pseudomonas aeruginosaM E Valiant, E C Gilfillan, H H Gadebusch, et al.
The Journal of Antibiotics|June 1, 1978
Diastereomeric 7-ureidoacetyl cephalosporins. III. Contribution of D- and L-isomers to the growth inhibiting activities of 7alpha-H and 7alpha-OCH3 derivatives for gram-positive and gram-negative bacteriaH H Gadebusch, H I Basch, P Lukaszow, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1974
Cephradine: absorption, excretion, and tissue distribution in animals of a new cephalosporin antibioticI Weliky, H H Gadebusch, K Kripalani, et al.
The Journal of Antibiotics|July 1, 1972
Comparative chemotherapeutic activities of heptaene macrolide antifungal antibiotics in experimental candidiasisF E Pansy, W P Jambor, J Wilber-Murphy, et al.
Pageof 5